pharmaxi.ua

What It Is

Pharmaxi is a mid-sized contract research organization (CRO) headquartered in Kyiv, Ukraine. It focuses on Phase II-IV pharmaceutical clinical trials and clinical evaluation of medical devices across Eastern Europe, covering Ukraine, Poland, neighboring CIS countries, and other CEE states. Positioned as a regional clinical research service provider with controllable costs and flexible delivery, it has completed more than 20 multi-national clinical research projects spanning 10 countries to date, with clients including global enterprises such as MSD and Draeger.

Core Features and Services

Pharmaxi offers end-to-end services from study design to final study report delivery, and can also provide individual services on demand, including clinical operations, medical writing, biostatistics, regulatory affairs, data management, project management, and vendor management. It has independently developed OnlineCRF, an electronic data capture system that complies with US FDA 21 CFR Part 11 regulations. The system supports remote trial monitoring and online data validation, improving project transparency and reducing on-site operational costs. It also coordinates third-party vendors to handle non-core processes including trial drug logistics, customs clearance, warehousing, and insurance, enabling one-stop service through a single point of contact.

Strengths and Weaknesses Analysis

Strengths: Compared to Western Europe and North America, clinical trial approval processes in Eastern European countries like Ukraine are shorter and costs are lower, and subject recruitment is more efficient thanks to a centralized healthcare system. Core members of the Pharmaxi team have more than 15 years of industry experience, are deeply familiar with regional regulations, and even participate in legislative consultation for clinical research in Ukraine. Their professional capabilities are widely recognized by industry clients.
Weaknesses: No pricing information is publicly available on the official website, and you have to book a consultation to get a quote. There is no Chinese-language service, which is not user-friendly for Chinese clients. Its core operating region is affected by the current geopolitical situation, which carries certain potential risks.

Ideal Users and Access from China

This service is suitable for global pharmaceutical companies, biotech firms, and medical device manufacturers that need to deploy clinical research in Eastern Europe and control R&D costs. Chinese users can access the official website directly, no VPN is required.